Navigation Links
'Proud Hands' Book Released to Benefit the American Parkinson Disease Association

Teva Neuroscience Sponsors Book That Celebrates Daily Victories Over


NEW YORK, April 21 /PRNewswire/ -- Most people view an illness as a handicap. A number of people with Parkinson's disease (PD), an age-related degenerative disorder of the brain which normally affects people over the age of 60, have each penned their own inspirational story compiled in a new book titled "Proud Hands." "Proud Hands" celebrates the daily victories of 28 people from across the country who are affected by PD, and depicts the various activities some use to live well despite their illness. The book is a combination of personal photos and stories submitted by both patients and caregivers to provide encouragement to the more than 1 million people in the U.S. who are affected by PD.

"Proud Hands" features a celebrity foreword by Holly Robinson Peete, actress and Parkinson's advocate. Peete has a passion to help improve the quality of life for people who are affected by PD. She has dedicated herself to helping others live well with the disease, not just financially, but physically and emotionally, too. Peete and her husband Rodney founded the HollyRod Foundation in 1997 in honor of Peete's dad, Matt Robinson, who battled PD for many years.

Holly Robinson Peete will be on site to launch "Proud Hands" at the annual Parkinson's Unity Walk Saturday, April 26, 2008, at Central Park in New York City. In addition, several storytellers from "Proud Hands," and representatives from Teva Neuroscience and the American Parkinson Disease Association (APDA) will be there to talk about the importance of learning to live well with PD. Participants attending the Unity Walk will be able to reserve a copy of "Proud Hands" at the Teva Neuroscience booth.

"It's efforts such as this one made by Teva Neuroscience that allows my organization, HollyRod Foundation, to continue serving the PD community throughout the United States," said Holly Robinson Peete. "The 'Proud Hands' book is a great way to create awareness about a disease that affects the lives of so many people and, at the same time, give hope to those who have the disease."

"Proud Hands" is sponsored by Teva Neuroscience, marketer of the Parkinson's drug AZILECT(R) (rasagiline tablets). The book will be available through the APDA for a $15 donation, which will go to assist the organization in its research, support, and education initiatives. More information on the book is available online at

"It is important to let the community know that Parkinson's disease does not have to be the entire story of a person's life. The 'Proud Hands' book is a way for those affected by the disease to share this message with the world. We're honored that these courageous and inspirational people have allowed us to help spread their story that they might serve as an example to others," said Mike Sheehy, product manager for Teva Neuroscience.

The photos and stories in "Proud Hands" range both in style and content, demonstrating the full lives that people with PD can lead. Participants also vary in age and background, including those who have young-onset PD. Some examples are:

-- Yoga instructor Paul Zeiger, who has created a special yoga program for

people with PD to improve flexibility, strength and balance.

-- Elena Tuero, a mother of three, who began her career as an artist 17

years after her diagnosis at age 27, and donates many of her paintings

to help raise funds for Parkinson's research.

-- Bill Hillman, a retired coach who created and launched exercise videos

to help alleviate the symptoms of PD on You Tube


For more information visit


AZILECT(R) (rasagiline tablets) is indicated for the treatment of the signs and symptoms of Parkinson's disease both as initial therapy alone and to be added to levodopa later in the disease. The effectiveness of AZILECT was shown in patients with early PD who were receiving AZILECT as initial therapy alone and who were not receiving any other PD therapy. The effectiveness of AZILECT as adjunct therapy was shown in patients with PD who were treated with levodopa.

Important Safety Information:

-- Patients should not take AZILECT if they are currently taking

meperidine as it could possibly result in a serious reaction such as

coma or death.

-- Patients should not take AZILECT with tramadol, methadone,

propoxyphene, dextromethorphan, St. John's wort, mirtazapine, or


-- Patients should not take AZILECT with other monoamine oxidase

inhibitors (MAOIs), amphetamines, cold remedies containing

decongestants and weight-reducing preparations containing

pseudoephedrine, phenylephrine, phenylpropanolamine, or ephedrine in

order to avoid a possibly dangerous increase in blood pressure.

Symptoms of this reaction include severe headache, blurred vision,

difficulty thinking, seizures, chest pain, unexplained nausea or

vomiting, or signs or symptoms of a stroke. Patients or caregivers

should seek immediate medical attention if these symptoms or other

unusual symptoms occur.

-- In order to prevent a possibly dangerous increase in blood pressure,

patients taking AZILECT should avoid foods and beverages high in

tyramine content such as aged cheeses, air-dried meats, pickled

herring, yeast extract, aged red wines, tap/draft beers, sauerkraut,

and soy sauce.

-- Patients taking AZILECT(R) (rasagiline tablets) should not have

elective surgery requiring general anesthesia, and should not receive

cocaine or other local anesthesia that contains ingredients that could

raise blood pressure.

-- Patients should inform their physician if they are taking, or planning

to take, any prescription or over-the-counter drugs, especially

antidepressants and ciprofloxacin.

-- Patients with moderate to severe liver disease or a tumor of the

adrenal gland should not take AZILECT.

-- All PD patients are advised to monitor for melanoma (skin cancer)

frequently and see a dermatologist on a regular basis.

Side effects seen with AZILECT alone are headache, joint pain and indigestion; and when taken with levodopa are uncontrolled movements (dyskinesias), accidental injury, nausea, weight loss, constipation, low blood pressure when standing, joint pain, vomiting, dry mouth, rash, and sleepiness. Patients should tell their doctor about these and any other side effects they experience when taking AZILECT.

About Parkinson's Disease

Parkinson's disease is an age-related degenerative disorder of the brain. Symptoms can include tremor, stiffness, slowness of movement, and impaired balance. An estimated 1 million Americans have the disease, which usually affects people over the age of 60.

About Teva

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), headquartered in Israel, is among the top 20 pharmaceutical companies in the world. The company develops, manufactures, and markets innovative and generic human pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Europe. Teva's innovative R&D focuses on developing novel drugs for diseases of the central nervous system.

Teva's U.S. innovative product marketing subsidiary, Teva Neuroscience, Inc., promotes AZILECT in the United States. AZILECT is a registered trademark of Teva Pharmaceutical Industries Ltd. Please visit for additional important information.

Please see enclosed additional important information.


SOURCE Teva Neuroscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
2. @ease Spa is Proud to Participate in Spa Week
3. When Should Children Wash Their Hands?
4. Clean Hands are Key to Fighting Cold, Flu Germs
5. Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work
6. SafeHands School Program to Help Fight Spread of MRSA Staph Virus
7. Cleaning Hands, Saving Lives: The Spread of Staph Can Be Stopped
8. Gynecologists Get First Hands-On Experience With Simbionix LAP Mentor(TM)
9. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
10. Two Little Hands Productions, Creators of Popular Childrens TV Series Signing Time, Debuts Second Season at This Years Toy Fair 2008
11. Qiao Xing Mobiles CECT Subsidiary Releases Newest Handset Model; C7000A Offers Cardiograph, 120 Days Ultra-Long Standby and 3.0 LCD Screen
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: